表 1. Multivariate Cox regression analysis of factors influencing recurrence-free survival (RFS) of patients with overall recurrence.
影响整体复发患者RFS的多因素Cox回归分析
| Variables | RFS | |||
| Hazard ratio | 95%CI | P | ||
| ER: Estrogen receptor; PR: Progesterone receptor; Follow-up: No adjuvant therapy or only endocrine therapy after surgery; CT: Chemotherapy; RT: Radiotherapy; CI: Confidence interval. | ||||
| FIGO stage | ||||
| Ⅰ | 1.000 | Ref | ||
| Ⅱ | 2.624 | 0.898-7.662 | 0.078 | |
| Ⅲ | 3.432 | 1.451-8.116 | 0.005 | |
| Grade | ||||
| 1 | 1.000 | Ref | ||
| 2 | 1.519 | 0.343-6.723 | 0.582 | |
| 3 | 1.547 | 0.329-7.273 | 0.580 | |
| Pathological type | ||||
| Endometrioid carcinoma | 1.000 | Ref | ||
| Special types | 1.614 | 0.894-2.915 | 0.112 | |
| Myometrial invasion | ||||
| <1/2 | 1.000 | Ref | ||
| ≥1/2 | 1.601 | 0.885-2.896 | 0.120 | |
| Cervical stromal invasion | ||||
| No | 1.000 | Ref | ||
| Yes | 1.464 | 0.663-3.233 | 0.345 | |
| Ki-67 positive percentage | 1.015 | 1.002-1.028 | 0.025 | |
| ER positive percentage | 0.985 | 0.975-0.995 | 0.005 | |
| PR positive percentage | 0.996 | 0.985-1.007 | 0.465 | |
| P53 positive percentage | 1.008 | 1.000-1.015 | 0.054 | |
| Adjuvant therapy | ||||
| Follow-up | 1.000 | Ref | ||
| Only CT | 0.624 | 0.286-1.358 | 0.234 | |
| Only RT | 0.284 | 0.035-2.345 | 0.243 | |
| CT and RT | 0.686 | 0.300-1.570 | 0.372 | |